Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, TimesSquare Capital Management U.S. Small_Mid Cap Growth Strategy. This analysis is provided for institutional research purposes only and is not investment advice.
"TimesSquare's small/mid-cap growth strategy underperformed in Q4 despite strong cybersecurity and biotech holdings. The manager actively trimmed winners and added to quality names on weakness, positioning for structural growth themes including cybersecurity demand, healthcare innovation, and industrial automation addressing labor shortages."
TimesSquare's U.S. Small/Mid Cap Growth Strategy delivered a 9.53% net return in Q4 2023, slightly underperforming the Russell 2500 Growth Index's 12.59% return. The portfolio benefited from strong performance in cybersecurity (CyberArk +34%), biotechnology (Ascendis Pharma +34%, RAPT Therapeutics +48%), and technology companies like JFrog (+36%) and Synaptics (+28%). The manager actively managed positions, trimming winners like TPG (+46%) and ESAB (+23%) while adding to positions like Legend Biotech and AtriCure on weakness. Key detractors included Flywire (-28%) and ProAssurance (-27%), leading to position exits and trims. The strategy emphasizes companies addressing structural trends including cybersecurity demand driven by high-profile breaches, healthcare innovation with normalized FDA processes, and industrial automation addressing labor challenges. Looking ahead to 2024, the manager expects continued fundamental improvements across portfolio companies while monitoring central bank policies and global election outcomes that could impact markets.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
The manager demonstrates moderate-high conviction through active position management, naming specific holdings with detailed rationales, and clear thesis explanations for each position. The portfolio holds 90-120 stocks with concentrated discussion on key names, showing selective conviction in individual positions while maintaining diversification.
Growth Outlook
The manager expresses cautious optimism about 2024, noting that many portfolio companies showed improving fundamentals toward the end of 2023 that are expected to continue. However, this is tempered by concerns about central bank timing and global election uncertainty.
Risk Appetite
The manager demonstrates selective risk appetite, actively trimming positions that performed well (TPG, ESAB) while adding to quality names on weakness (Legend Biotech, AtriCure). The approach shows measured deployment rather than aggressive risk-taking.
Capital Deployment
The manager engaged in net trimming activity during the quarter, reducing positions in winners like TPG and ESAB while selectively adding to a few names on weakness. The overall activity suggests modest de-risking rather than aggressive deployment.
Forward Guidance
The manager plans to continue monitoring and fine-tuning positions based on fundamentals, with a focus on protecting assets. The approach is cautious and measured rather than aggressively deploying capital.
Language Signal
The letter contains balanced language with both positive developments (improving fundamentals, structural growth themes) and risk acknowledgments (central bank uncertainty, election impacts). Slightly more constructive than bearish overall.
Perceived Risk
The manager acknowledges several specific risks including central bank policy uncertainty, global election impacts, and sector-specific challenges like EV demand/supply imbalances. Risks are discussed but not characterized as systemic threats.
Opportunity Density
The manager identifies selective opportunities across multiple sectors including cybersecurity, biotechnology, and industrial automation. While not describing an abundant opportunity set, the manager finds compelling ideas in specific structural growth themes.
Time Horizon
The manager emphasizes multi-year structural trends like cybersecurity demand, industrial automation, and supply chain reshoring. The approach focuses on fundamental business improvements over several years rather than near-term catalysts, though some positions have specific milestone expectations.
